u 73343 has been researched along with prostaglandin d2 in 1 studies
Studies (u 73343) | Trials (u 73343) | Recent Studies (post-2010) (u 73343) | Studies (prostaglandin d2) | Trials (prostaglandin d2) | Recent Studies (post-2010) (prostaglandin d2) |
---|---|---|---|---|---|
97 | 0 | 6 | 3,454 | 78 | 751 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fang, Q; Kim, HJ; Kobayashi, T; Kohyama, T; Liu, X; Rennard, SI; Wen, FQ; Wyatt, TA | 1 |
1 other study(ies) available for u 73343 and prostaglandin d2
Article | Year |
---|---|
PGD(2) modulates fibroblast-mediated native collagen gel contraction.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Cells, Cultured; Collagen; Cyclic GMP; Enzyme Inhibitors; Estrenes; Fatty Acids, Unsaturated; Fibroblasts; Gels; Humans; Hydrazines; Indoles; Lung; Mesylates; Naphthalenes; Prostaglandin Antagonists; Prostaglandin D2; Protein Kinase C; Pyrroles; Pyrrolidinones; Rats; Receptors, Immunologic; Receptors, Prostaglandin; Thionucleotides; Type C Phospholipases; Wound Healing; Xanthenes; Xanthones | 2002 |